Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-19-004473
Filing Date
2019-12-02
Accepted
2019-12-02 17:13:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 CLOVIS ONCOLOGY, INC. p19-2294sc13ga.htm SC 13G 67168
2 JOINT FILING AGREEMENT p19-2294exhibit.htm EX-99 5518
  Complete submission text file 0000902664-19-004473.txt   74400
Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86488 | Film No.: 191263885
SIC: 2834 Pharmaceutical Preparations